{"id":4429,"date":"2026-06-14T14:50:02","date_gmt":"2026-06-14T12:50:02","guid":{"rendered":"https:\/\/exist.de\/?post_type=success-story&#038;p=4429"},"modified":"2026-06-14T16:29:54","modified_gmt":"2026-06-14T14:29:54","slug":"noxon","status":"publish","type":"success-story","link":"https:\/\/exist.de\/en\/success-stories\/noxon\/","title":{"rendered":"Noxon"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true,"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":""},"program":[],"class_list":["post-4429","success-story","type-success-story","status-publish","hentry"],"acf":{"story_topline":"Success Story","story_title":"Noxon","story_logo":4420,"story_hero_image":4430,"page_blocks":[{"block_type":"content","col_position":"","col_media_position":"col_media_left","col_headline_position":"headline_position_content","col_image":"","col_video":"","col_video_poster":"","col_videoloop":"","col_logo":"","col_shortcode":"","col_headline":"","col_subline":"","col_leadtext":"","col_text":"","col_list":null,"col_linklist":null,"col_button_label":"","col_button_internal":"","col_button_external":"","cards_style":"","cards_color_scheme":"Standard (hellgrau)","cards_title":"","cards_desc":"","cards_items":null,"downloads_title":"","downloads_items":"","blocks_style":"","blocks_title":"","blocks_items":null,"hl_alignment":"","hl_title":"","hl_description":"","hl_button_label":"","hl_button_internal":"","hl_button_external":"","ban_style":"","ban_color_scheme":"Standard (hellgrau)","ban_image":"","ban_image_position":"left","ban_headline":"","ban_text":"","ban_button_label":"","ban_button_internal":"","ban_button_external":"","cnt_headline":"Muskeltechnologie f\u00fcr neue Therapieans\u00e4tze","cnt_leadtext":"Wie lassen sich Therapien individueller gestalten und besser in den Alltag von Patien-tinnen und Patienten integrieren? Mit dieser Frage besch\u00e4ftigt sich das M\u00fcnchner Star-tup Noxon. Das Team entwickelt ein tragbares Medizintechnologiesystem, das Muskelak-tivit\u00e4t im Alltag erfasst und gleichzeitig gezielte Stimulation erm\u00f6glicht. ","cnt_text":"<p>Auf dem Weg von der Forschung in die Unternehmensgr\u00fcndung spielte das exist Gr\u00fcndungsstipendium eine entscheidende Rolle. Wie Co-Founder und CEO Maria Neugschwender berichtet, war die fr\u00fche Gr\u00fcndungsphase von gro\u00dfer Unsicherheit gepr\u00e4gt, sowohl bei der technologischen Weiterentwicklung als auch beim Aufbau der notwendigen Unternehmensstrukturen. Die F\u00f6rderung habe dem Team den finanziellen Freiraum gegeben, sich vollst\u00e4ndig auf die Entwicklung des Vorhabens zu konzentrieren und gleichzeitig die organisatorischen Grundlagen des Unternehmens zu schaffen. Besonders wertvoll sei zudem die enge und partnerschaftliche Zusammenarbeit mit dem universit\u00e4ren Umfeld gewesen. Auch die M\u00f6glichkeit, von Beginn an \u00fcber eigene Arbeits- und Entwicklungsr\u00e4ume zu verf\u00fcgen, habe wesentlich dazu beigetragen, ein starkes Team aufzubauen und eine Unternehmenskultur zu entwickeln, die das Startup bis heute pr\u00e4gt.<\/p>\r\n<p>Heute arbeitet Noxon daran, die Technologie weiter in Richtung klinischer Anwendung und individualisierter Therapiel\u00f6sungen zu entwickeln. Seit der Gr\u00fcndung im Jahr 2022 hat das Unternehmen wichtige Meilensteine erreicht und konnte zuletzt eine mehrmillionenschwere Seed-Finanzierungsrunde abschlie\u00dfen. Die Entwicklung von Noxon zeigt beispielhaft, wie exist dazu beitr\u00e4gt, wissenschaftliche Innovationen in erfolgreiche Gr\u00fcndungsvorhaben zu \u00fcberf\u00fchren und Forschungsteams auf ihrem Weg in den Markt gezielt zu unterst\u00fctzen.<\/p>\r\n","cnt_cta_style":"button","cnt_button_label":"Zur Website","cnt_button_internal":"","cnt_button_external":"https:\/\/noxon.io\/","cnt_cta_textlink_label":"","cnt_cta_textlink_internals":"","cnt_cta_textlink_externals":"","cnt_media_width":"normal","cnt_image":"","cnt_image_caption":"","cnt_video":"","cnt_video_poster":"","quote_text":"","quote_name":"","quote_role":"","contact_image":"","contact_name":"","contact_role":"","contact_link_label":"","contact_link_url":"","anchor_preview":"muskeltechnologie-fuer-neue-therapieansaetze"}],"story_program_program_taxonomy":false},"_links":{"self":[{"href":"https:\/\/exist.de\/en\/wp-json\/wp\/v2\/success-story\/4429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/exist.de\/en\/wp-json\/wp\/v2\/success-story"}],"about":[{"href":"https:\/\/exist.de\/en\/wp-json\/wp\/v2\/types\/success-story"}],"wp:attachment":[{"href":"https:\/\/exist.de\/en\/wp-json\/wp\/v2\/media?parent=4429"}],"wp:term":[{"taxonomy":"program","embeddable":true,"href":"https:\/\/exist.de\/en\/wp-json\/wp\/v2\/program?post=4429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}